Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Furst

Showing results (171-180 of 251) with videos related to

Pageof 26
Sort By:
The Journal of Rheumatology|December 1, 1987
Gold pharmacokinetics in breast milk and serum of a lactating womanT W Rooney, A Lorber, P Veng-Pedersen, et al.
Journal of the American Dental Association (1939)|June 1, 1977
Oral radiographic changes in patients with progressive systemic sclerosis (scleroderma)S C White, N W Frey, D D Blaschke, et al.
The American Journal of Medicine|February 1, 1994
Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse eventsK G Saag, R Koehnke, J R Caldwell, et al.
Arthritis and Rheumatism|August 18, 2001
Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosisK L Johnson, J L Nelson, D E Furst, et al.
Arthritis and Rheumatism|July 11, 2012
Brief report: effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: a prospective single-center, open-label pilot studyRajeev Saggar, D Khanna, S Shapiro, et al.
Clinical and Experimental Immunology|June 10, 2010
Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma)S P Atamas, I G Luzina, J Ingels, et al.
Biopharmaceutics & Drug Disposition|October 1, 1983
Biliary secretion of sulindac and metabolites in manM R Dobrinska, D E Furst, T Spiegel, et al.
Annals of the Rheumatic Diseases|August 6, 2008
Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability studyP J Mease, K Hobbs, A Chalmers, et al.
Arthritis and Rheumatism|October 1, 1987
Serum concentrations of salicylate and naproxen during concurrent therapy in patients with rheumatoid arthritisD E Furst, E Sarkissian, K Blocka, et al.
Clinical Pharmacology and Therapeutics|November 19, 2016
Model-Informed Development and Registration of a Once-Daily Regimen of Extended-Release TofacitinibM Lamba, M M Hutmacher, D E Furst, et al.
Pageof 26

Showing results (171-180 of 251) with videos related to

Sort By:
Pageof 26
The Journal of Rheumatology|December 1, 1987
Gold pharmacokinetics in breast milk and serum of a lactating womanT W Rooney, A Lorber, P Veng-Pedersen, et al.
Journal of the American Dental Association (1939)|June 1, 1977
Oral radiographic changes in patients with progressive systemic sclerosis (scleroderma)S C White, N W Frey, D D Blaschke, et al.
The American Journal of Medicine|February 1, 1994
Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse eventsK G Saag, R Koehnke, J R Caldwell, et al.
Arthritis and Rheumatism|August 18, 2001
Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosisK L Johnson, J L Nelson, D E Furst, et al.
Arthritis and Rheumatism|July 11, 2012
Brief report: effect of ambrisentan treatment on exercise-induced pulmonary hypertension in systemic sclerosis: a prospective single-center, open-label pilot studyRajeev Saggar, D Khanna, S Shapiro, et al.
Clinical and Experimental Immunology|June 10, 2010
Stimulation with type I collagen induces changes in gene expression in peripheral blood mononuclear cells from patients with diffuse cutaneous systemic sclerosis (scleroderma)S P Atamas, I G Luzina, J Ingels, et al.
Biopharmaceutics & Drug Disposition|October 1, 1983
Biliary secretion of sulindac and metabolites in manM R Dobrinska, D E Furst, T Spiegel, et al.
Annals of the Rheumatic Diseases|August 6, 2008
Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability studyP J Mease, K Hobbs, A Chalmers, et al.
Arthritis and Rheumatism|October 1, 1987
Serum concentrations of salicylate and naproxen during concurrent therapy in patients with rheumatoid arthritisD E Furst, E Sarkissian, K Blocka, et al.
Clinical Pharmacology and Therapeutics|November 19, 2016
Model-Informed Development and Registration of a Once-Daily Regimen of Extended-Release TofacitinibM Lamba, M M Hutmacher, D E Furst, et al.
Pageof 26